Fresenius Takes Full Control Of Spanish Biz In €750M Deal

Дата публикации: 01-10-2026 08:51:42

German healthcare company Fresenius said Thursday it has acquired full ownership of a Spanish biopharmaceutical business for up to €750 million ($847 million) in a deal that will allow it to develop, manufacture and sell biopharmaceutical drugs.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Radiopharmaceutical Dealmaking Continues With Telix’s $1.65B ITM Acquisition	0	8.67	22-09-2026
2	Técnicas Reunidas gana un contrato de 1.430 millones de euros para una planta de gas en Oriente Medio	0	8.04	13-08-2026
3	Hyundai Mobis To Sell Unit To Car Parts Supplier For $443M	0	12.15	30-09-2026
4	Rexel Raises €500M To Help Fund $1.4B GCG Buy	0	15.62	29-09-2026
5	GSK enters agreement to acquire RAPT Therapeutics	0	8.62	20-01-2026
6	Gene Silencing-Biotech ADARx Makes Some Noise With $535M Stock Market Debut	0	12	28-09-2026
7	GSK completes acquisition of 35Pharma Inc.	0	3.99	15-04-2026
8	Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform	0	8.53	29-09-2026
9	CriteriaCaixa invertirá 250 millones en un fondo europeo para escalar empresas	0	16.53	07-09-2026
10	GSK completes acquisition of RAPT Therapeutics	0	4.05	03-03-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.13. Источник: www.law360.com.